Sanford Hillsberg, Director at RXI PHARMACEUTICALS CORP (RXII), sold 25,000 shares at $5.66 ($142K) on 2010-03-26, disclosed to the SEC on 2010-03-30.
Open-market sale of $142k RXII by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| LBIO | SELL | 2015-09-09 | $227K | — | Filing → |
| LBIO | SELL | 2015-08-04 | $265K | — | Filing → |
| LBIO | SELL | 2015-05-07 | $500K | — | Filing → |